Wegovy

Wegovy is a once-weekly injectable medication containing semaglutide, manufactured by Novo Nordisk and clinically proven to support significant weight loss. It works by mimicking the GLP-1 hormone, which reduces appetite, slows digestion, and helps you feel full for longer. At the Pharmacy Weight Loss Andover clinic, Wegovy is prescribed as part of a structured weight management programme.

The starting dose of Wegovy 0.25mg costs £69.00 per month for weeks 1 to 4, making it one of the most accessible entry points for semaglutide treatment. As your dose increases, pricing adjusts accordingly to reflect the higher strength. The Pharmacy Weight Loss Andover clinic provides full pricing transparency before you commit to treatment.

Wegovy at the maintenance dose of 2.4mg costs £179.00 per month, which applies from week 17 onwards once you have completed the gradual dose escalation. This is the full therapeutic dose recommended for long-term weight management with semaglutide. The Pharmacy Weight Loss Andover clinic will guide you through each dose stage before you reach this point.

Yes, Wegovy is a prescription-only medication and cannot be purchased without a valid prescription from a qualified prescriber. The Pharmacy Weight Loss Andover clinic conducts a clinical consultation to assess your eligibility and issue a prescription where appropriate. You should never purchase semaglutide from an unregulated source, as this carries serious health risks.

Wegovy is typically prescribed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related health condition such as type 2 diabetes or high blood pressure. It is not suitable for everyone, including those who are pregnant or have a personal or family history of certain thyroid conditions. The Pharmacy Weight Loss Andover clinic will carry out a full medical assessment to confirm whether Wegovy is right for you.

Most patients using Wegovy begin to notice reduced appetite and early weight loss within the first four weeks at the 0.25mg starting dose. Clinically significant weight loss is typically seen within 12 to 16 weeks as the dose increases towards the therapeutic range. Results vary between individuals, and the Pharmacy Weight Loss Andover clinic will monitor your progress throughout your treatment.

The most commonly reported side effects of Wegovy include nausea, vomiting, diarrhoea, constipation, and stomach discomfort, particularly during the early weeks of treatment. These side effects are often mild to moderate and tend to improve as your body adjusts to semaglutide. The gradual dose escalation plan used at the Pharmacy Weight Loss Andover clinic is designed specifically to minimise these effects.

Yes, the Pharmacy Weight Loss Andover clinic offers a straightforward process to complete your consultation and, if eligible, have Wegovy delivered directly to your Andover address. Delivery is handled securely to ensure the medication is stored correctly during transit. You can begin your consultation quickly and receive your first month's supply of Wegovy without needing to attend in person.

Wegovy contains semaglutide at doses of up to 2.4mg, which is a higher dose than found in the diabetes medication Ozempic and is specifically licensed for weight management. Compared to other GLP-1 treatments, Wegovy has robust clinical trial data showing average weight loss of around 15% of body weight over 68 weeks. The Pharmacy Weight Loss Andover clinic can help you decide whether Wegovy or an alternative is better suited to your needs.

Wegovy follows a gradual escalation starting at 0.25mg for £69.00 per month, rising to 0.5mg at £89.00 per month from weeks 5 to 8. The dose continues to increase every four weeks until you reach the full maintenance dose of 2.4mg. The Pharmacy Weight Loss Andover clinic manages this entire escalation plan to support both your safety and your weight loss results.

Wegovy is specifically designed for people who have struggled to lose weight through diet and exercise alone, making it a strong option for those who have tried and not achieved lasting results with other approaches. Semaglutide acts directly on the brain's appetite regulation centres, which is a different mechanism to lifestyle changes or older weight loss medications. The Pharmacy Weight Loss Andover clinic will review your weight loss history as part of your consultation to confirm suitability.

Clinical studies show that the greatest weight loss benefits with Wegovy are seen after 16 to 20 weeks, once patients have reached or are approaching the 2.4mg maintenance dose. Wegovy is intended for long-term use, and stopping treatment early can lead to weight being regained. The Pharmacy Weight Loss Andover clinic provides ongoing support to help you stay on track and achieve sustainable results with semaglutide.